• Mashup Score: 6

    An 84-year-old haemodialyzed man was referred to our centre for left atrial appendage closure (LAAC). His medical history included paroxysmal atrial fibrilation

    Tweet Tweets with this article
    • A thunder out of the blue: pulmonary artery injury during percutaneous left atrial appendage closure. https://t.co/XYd2S0zrun #LAAC #percutaneous #complication #cardiotwitter @escardio @ESC_Journals https://t.co/DsznLnoio1

  • Mashup Score: 0

    February 24, 2023 —  Abiomed, Inc., part of Johnson & Johnson MedTech[1], announced that results from a study on Impella-supported high-risk percutaneous coronary intervention (HRPCI) patients will be presented during the upcoming Cardiovascular Research Technologies (CRT) 2023 Conference in Washington, DC from Feb. 25-28. Abiomed’s booth (#503) and Saturday’s Power Break lunch symposium will…

    Tweet Tweets with this article
    • @DAICeditor @Abiomed @CRT_meeting #Abiomed announced that results from a study on #Impella-supported high-risk #percutaneous #coronary #intervention (#HRPCI) patients will be presented at #CRT23: https://t.co/ksR7d3Qjac

  • Mashup Score: 0

    March 31, 2022 — In accordance with its commitment to patient safety, Medtronic recently voluntarily recalled a subset of its IN.PACT Admiral and IN.PACT AV Paclitaxel-coated Percutaneous Transluminal Angioplasty (PTA) balloon catheters due to the potential for pouch damage resulting in a loss of sterility. Approximately 6,000 IN.PACT Admiral catheters and 3 IN.PACT AV catheters distributed to…

    Tweet Tweets with this article
    • @DAICeditor @Medtronic #RECALLED A subset of the #IN_PACT_Admiral and #IN_PACT_AV #Paclitaxel-coated #Percutaneous #Transluminal #Angioplasty #balloon_catheters have been recalled due to the potential for pouch damage resulting in loss of sterility: https://t.co/oVN0ufoGAx